Inhibitor Therapeutics, Inc. (INTI) Insider Trading & SEC Filings

Updated Jul 17, 2026 · Last SEC filing 2026-06-24

Inhibitor Therapeutics, Inc. (INTI) has filed 2 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-24. InsiderAlpha tracks every INTI SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Inhibitor Therapeutics, Inc. (INTI)

SEC CIK	0001042418

90-Day SEC Filing Activity

Form 4 filings (90d)	2
Latest Form 4 filing	2026-06-24

Recent INTI Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-05-05	Vasisht Niraj	Director	A — Grant or award	50.0K	$0.00	—	SEC
2026-05-04	Jerman Michael Allen	Director	A — Grant or award	50.0K	$0.00	—	SEC
2025-04-01	Jerman Michael Allen	Director	A — Grant or award	50.0K	$0.00	—	SEC
2025-04-01	SEARS SAMUEL P JR	Director	A — Grant or award	50.0K	$0.00	—	SEC
2025-04-01	OSMAN RONALD E	Director	A — Grant or award	50.0K	$0.00	—	SEC
2025-04-01	Vasisht Niraj	Director	A — Grant or award	50.0K	$0.00	—	SEC
2025-04-01	Yanez Michelle	Director	A — Grant or award	50.0K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Inhibitor Therapeutics, Inc. (INTI). Updated in real time as new filings are submitted to the SEC.

Most-Active INTI Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Jerman Michael Allen	1	—
Vasisht Niraj	1	—

Recent INTI Form 8-K Material Events

2026-04-01 — Item 7.01, 9.01 · Legal · negative [SEC]
Inhibitor Therapeutics initiated litigation against an institutional investor on March 30, 2026, for failing to complete a $3 million financing commitment under a Securities Purchase Agreement signed in February 2026. The investor failed to fund the promised investment of $3 mill
2026-04-01 — Item 8.01, 9.01 · Clinical · neutral [SEC]
Inhibitor Therapeutics issued a press release on March 31, 2026 providing a clinical, formulation, and intellectual property update on its itraconazole program for Gorlin Syndrome. The filing contains forward-looking statements but no specific clinical trial results, regulatory a
2026-02-24 — Item 1.01, 9.01 · Financing · neutral [SEC]
Inhibitor Therapeutics entered into a Securities Purchase Agreement on February 19, 2026 to raise $3 million through the sale of 12 million common shares at $0.25 per share plus a warrant to purchase 7 million additional shares at $0.35 per share. The financing had not yet closed

Recent Insider Filings

2026-06-24 — Jerman Michael Allen (Director)
2026-06-01 — Vasisht Niraj (Director)
2024-04-01 — Jerman Michael Allen (Director)
2024-04-01 — SEARS SAMUEL P JR (Director)
2024-04-01 — OSMAN RONALD E (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in INTI insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

INTI Insider Trading — FAQ

What is the latest insider trade for INTI?: Inhibitor Therapeutics, Inc. (INTI) had 2 insider filings in the last 90 days, with the most recent on 2026-06-24. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying INTI stock?: 0 insider purchases of INTI were filed in the last 90 days.
How many insiders are selling INTI stock?: 0 insider sales of INTI were filed in the last 90 days.
Where can I see INTI SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every INTI SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live INTI dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.